Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Comment by Smokey1958on Jan 11, 2022 3:44pm
128 Views
Post# 34305253

RE:RE:Please curb your enthusiasm...

RE:RE:Please curb your enthusiasm...Agreed, hk, which should have come based on the info from Cote's post on the updated overview from clinicaltrials.gov! Unfortunately that didn't happen. That does not absolve those who thought this was in anyway a means to circumvent that fact.

It was obviously deemed extreme and critical enough for the liason of the clinical trials to contact THRM management. Hopefully everyone has learned a lesson here ...and we can look forward to a great NR very soon.

Cheers!!!

hk1966 wrote: Thank you Admin however much of this could have been avoided with a proactive statement from mgmt along the lines of "the study is in progress still and we will update everyone once completed package has been sent into the FDA for review. 


<< Previous
Bullboard Posts
Next >>